Skip to main content

US ClosedU.S. Closed

Healthcare · Biotechnology

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical enterprise focused on creating biological therapies.

52W Range

57thpctl

Volume

0.57×avg

Market Cap

73.27MUSD

P/E Ratio

-1.0TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Cue Biopharma, Inc.

CUENASDAQ Capital Market·USD·Closed

Cue Biopharma, Inc.

CUENASDAQ·USD·Closed

$27.88

−0.99%

$27.88

−$0.28 (0.99%)

52W Range

57thpctl

Volume

0.57×avg

Mkt Cap

73.27MUSD

P/E

-1.0TTM

Div Yield

–ann

CUE: Cue Biopharma, Inc. Stock Analysis | finqOS